Wall Street climbs on vaccine bets, Goldman results

Credit: REUTERS/Lucas Jackson

By Noel Randewich

July 15 (Reuters) - U.S. stocks climbed on Wednesday, with the S&P 500 approaching its highest level in more than four months after promising early data for a potential COVID-19 vaccine and a strong quarterly report from Goldman Sachs.

Moderna Inc MRNA.Osurged 9.2% after a small-scale study showed its experimental COVID-19 vaccine produced high levels of virus-killing antibodies.

Travel-related stocks Carnival Corp CCL.N, Royal Caribbean Cruises Ltd RCL.N, Marriott International MAR.O and Wynn Resorts WYNN.O rose between 7% and 20%, with the S&P 1500 airlines index .SPCOMAIRup 10.0%.

The S&P 500 was on track to beat the technology-heavy Nasdaq Composite for a fourth straight session, a feat scored only twice since Wall Street launched its massive recovery last March.

Gains for the Nasdaq were capped by online retail giant Inc AMZN.O, video streaming platform Netflix Inc NFLX.O and Microsoft Corp MSFT.O which slipped after surging to record highs recently.

"The Moderna news woke everybody up again that this is not going to last forever, and there is light at the end of the tunnel. That is why you are seeing such a strong move today into those economically sensitive stocks," said Tim Ghriskey, Chief Investment Strategist Inverness Counsel in New York.

Adding to investors' enthusiasm, the Federal Reserve's Beige Book survey showed U.S. businesses saw an uptick in activity into the beginning of July as states eased restrictions to contain the novel coronavirus pandemic, but that but many were uncertain about the economic outlook.

However, the United States has failed to control the coronavirus and there is a high level of uncertainty over how much the pandemic will affect the economy, Philadelphia Federal Reserve Bank President Patrick Harker said, as a number of U.S. sunbelt states reported a surge in COVID-19 cases recently.

The three main U.S. stock indexes have recouped most of their losses from the coronavirus-led slump, with a raft of stimulus measures and encouraging economic data lifting the S&P 500 to about 5% below its record high hit in February.

At 2:28 p.m. ET (1828 GMT), the Dow Jones Industrial Average .DJI was up 0.79% at 26,854.26 points, while the S&P 500 .SPX gained 0.94% to 3,227.45.

The Nasdaq Composite .IXIC added 0.66% to 10,558.29.

Goldman Sachs GS.N rose 1.2% after it said its trading revenue doubled in the second quarter, driven by big swings in stock and bond markets since March.

Morgan Stanley MS.N gained 1.2% and Bank of America BAC.N rose 1.4% ahead of their results on Thursday. The broader banking index .SPXBK climbed 2.3%.

UnitedHealth Group Inc UNH.N fell 2.3% after warning of rising costs later this year as Americans catch up on less urgent surgeries halted by the coronavirus pandemic.

Advancing issues outnumbered declining ones on the NYSE by a 5.03-to-1 ratio; on Nasdaq, a 4.35-to-1 ratio favored advancers.

The S&P 500 posted 29 new 52-week highs and no new lows; the Nasdaq Composite recorded 67 new highs and two new lows.

(Additional reporting by Medha Singh and Devik Jain in Bengaluru Editing by Marguerita Choy)

((; (415) 677 2542; Reuters Messaging: Twitter: @randewich))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.